Cetera Advisor Networks’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$893K Buy
5,368
+106
+2% +$17.6K ﹤0.01% 1544
2023
Q4
$870K Buy
5,262
+131
+3% +$20.2K ﹤0.01% 1465
2023
Q3
$799K Buy
5,131
+1,297
+34% +$207K 0.01% 1433
2023
Q2
$598K Sell
3,834
-1,347
-26% -$215K ﹤0.01% 1596
2023
Q1
$840K Buy
5,181
+216
+4% +$34.9K 0.01% 1348
2022
Q4
$793K Sell
4,965
-1,023
-17% -$162K 0.01% 1325
2022
Q3
$843K Sell
5,988
-1,233
-17% -$186K 0.01% 962
2022
Q2
$1.05M Buy
+7,221
New +$1.08M 0.01% 864
2020
Q3
Sell
-586
Closed -$95K 1377
2020
Q2
$95K Buy
+586
New +$89.1K ﹤0.01% 1538
2018
Q2
Sell
-3,039
Closed -$362K 844
2018
Q1
$362K Sell
3,039
-658
-18% -$82.6K 0.02% 599
2017
Q4
$460K Sell
3,697
-620
-14% -$79.2K 0.02% 600
2017
Q3
$579K Buy
4,317
+14
+0.3% +$1.82K 0.03% 489
2017
Q2
$542K Buy
4,303
+523
+14% +$63.1K 0.03% 494
2017
Q1
$449K Buy
3,780
+230
+6% +$26.9K 0.02% 541
2016
Q4
$382K Buy
+3,550
New +$386K 0.02% 574
2014
Q1
Sell
-3,629
Closed -$323K 779
2013
Q4
$323K Buy
3,629
+236
+7% +$19.7K 0.02% 536
2013
Q3
$282K Buy
3,393
+479
+16% +$37.6K 0.02% 508
2013
Q2
$201K Buy
+2,914
New +$203K 0.02% 555

Other funds holding BBH

Cetera Advisor Networks's BBH Position: Q1 2024 in Review

Cetera Advisor Networks increased its VanEck Biotech ETF (BBH) stake by 2% in Q1 2024, buying an estimated $17.6K and bringing the position to 5,368 shares worth $893K. The position accounts for ﹤0.01% of the portfolio, ranked #1544.

Cetera Advisor Networks first reported a position in BBH in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.05M in Q2 2022. 113 funds tracked by Wall St. Rank hold BBH as of Q1 2024.

  • Cetera Advisor Networks held 5,368 shares of VanEck Biotech ETF worth $893K as of Q1 2024.
  • Cetera Advisor Networks bought 106 VanEck Biotech ETF shares in Q1 2024, an estimated $17.6K.
  • VanEck Biotech ETF made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1544 holding.
  • Cetera Advisor Networks first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 18 quarters since.
  • Cetera Advisor Networks's VanEck Biotech ETF position peaked at $1.05M in Q2 2022.
  • 113 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.